Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroGen

10.97
+0.42003.98%
Post-market: 10.970.00000.00%18:03 EDT
Volume:16.21K
Turnover:175.13K
Market Cap:44.36M
PE:-21.42
High:11.09
Open:10.78
Low:10.46
Close:10.55
52wk High:21.94
52wk Low:4.50
Shares:4.04M
Float Shares:3.62M
Volume Ratio:0.35
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5122
EPS(LYR):-11.8895
ROE:-1015.79%
ROA:-16.40%
PB:-0.20
PE(LYR):-0.92

Loading ...

BUZZ-FibroGen rises after company begins mid-stage study for prostate cancer therapy

Reuters
·
Sep 25

William Blair Remains a Hold on FibroGen (FGEN)

TIPRANKS
·
Sep 24

FibroGen Price Target Maintained With a $43.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 24

FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat

TIPRANKS
·
Sep 24

BRIEF-FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

Reuters
·
Sep 24

FibroGen Launches Phase 2 Trial of FG-3246 for mCRPC, Evaluates FG-3180 as Companion PET Imaging Biomarker

Reuters
·
Sep 24

FibroGen Inc - Interim Analysis of Trial Expected in 2H 2026

THOMSON REUTERS
·
Sep 24

FibroGen Inc - Topline Results of FG-3246 in Combination With Enzalutamide in Patients With Mcrpc Enzalutamide Expected Q4 2025

THOMSON REUTERS
·
Sep 24

FGEN Enhances Share Capital Management with Treasury Share Purchase

TIPRANKS
·
Sep 23

SEC charges former FibroGen CMO for false claims on clinical trial results

TIPRANKS
·
Sep 11

FibroGen Inc. Releases Proforma Financials Following $220 Million Sale of FibroGen China to AstraZeneca

Reuters
·
Sep 06

Press Release: FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

Dow Jones
·
Sep 02

FibroGen Inc. Gains Approval from China for Sale of FibroGen China to AstraZeneca, Closing Expected in Q3 2025

Reuters
·
Aug 18

FibroGen Inc - Sale of FibroGen China on Track to Close in 3Q 2025

THOMSON REUTERS
·
Aug 18

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

THOMSON REUTERS
·
Aug 18

FibroGen Inc. Reduces Cash Balance Requirement with Fourth Amendment to Financing Agreement

Reuters
·
Aug 14

FibroGen Shares up 14.8% After Q2 Results, Cash Flow Update

THOMSON REUTERS
·
Aug 12

Top Premarket Gainers

MT Newswires Live
·
Aug 12

FibroGen Q2 EPS $(1.88) Beats $(2.25) Estimate, Sales $1.35M Miss $2.63M Estimate

Benzinga
·
Aug 12

FibroGen Inc. Reports Q2 2025 Financial Results; Sale of FibroGen China to Boost Cash Runway into 2028

Reuters
·
Aug 12